Western Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
1,578
-20
| -1% | -$4.38K | 0.02% | 518 |
|
|
2025
Q1 | $358K | Sell |
1,598
-5
| -0.3% | -$1.12K | 0.02% | 473 |
|
|
2024
Q4 | $525K | Hold |
1,603
| – | – | 0.03% | 370 |
|
|
2024
Q3 | $481K | Buy |
1,603
+104
| +7% | +$31.2K | 0.03% | 478 |
|
|
2024
Q2 | $494K | Buy |
1,499
+11
| +0.7% | +$3.62K | 0.04% | 373 |
|
|
2024
Q1 | $589K | Buy |
1,488
+100
| +7% | +$39.6K | 0.05% | 328 |
|
|
2023
Q4 | $489K | Hold |
1,388
| – | – | 0.04% | 417 |
|
|
2023
Q3 | $521K | Hold |
1,388
| – | – | 0.04% | 379 |
|
|
2023
Q2 | $531K | Hold |
1,388
| – | – | 0.05% | 361 |
|
|
2023
Q1 | $481K | Buy |
1,388
+3
| +0.2% | +$1.04K | 0.04% | 377 |
|
|
2022
Q4 | $326K | Sell |
1,385
-1,801
| -57% | -$424K | 0.03% | 445 |
|
|
2022
Q3 | $778K | Buy |
3,186
+54
| +2% | +$13.2K | 0.04% | 374 |
|
|
2022
Q2 | $950K | Buy |
3,132
+146
| +5% | +$44.3K | 0.05% | 314 |
|
|
2022
Q1 | $1.23M | Buy |
2,986
+1,247
| +72% | +$512K | 0.06% | 299 |
|
|
2021
Q4 | $813K | Buy |
+1,739
| New | +$813K | 0.08% | 232 |
|
|
2021
Q2 | $613K | Buy |
1,709
+4
| +0.2% | +$1.44K | 0.06% | 315 |
|
|
2021
Q1 | $480K | Hold |
1,705
| – | – | 0.06% | 285 |
|
|
2020
Q4 | $483K | Sell |
1,705
-27
| -2% | -$7.65K | 0.07% | 260 |
|
|
2020
Q3 | $476K | Buy |
1,732
+10
| +0.6% | +$2.75K | 0.08% | 248 |
|
|
2020
Q2 | $391K | Sell |
1,722
-2
| -0.1% | -$454 | 0.07% | 266 |
|
|
2020
Q1 | $263K | Buy |
1,724
+24
| +1% | +$3.66K | 0.06% | 292 |
|
|
2019
Q4 | $256K | Sell |
1,700
-23
| -1% | -$3.46K | 0.04% | 343 |
|
|
2019
Q3 | $244K | Sell |
1,723
-1
| -0.1% | -$142 | 0.05% | 335 |
|
|
2019
Q2 | $216K | Buy |
+1,724
| New | +$216K | 0.03% | 371 |
|